Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

Ageing Research Reviews

Volumn 3, Issue 3, 2004, Pages 319-326

  Castellani, Rudy J ^a   Honda, Kazuhiro ^a   Zhu, Xiongwei ^a   Cash, Adam D ^a   Nunomura, Akihiko ^b   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Alzheimer disease; Microtubules; Mitochondria; Oxidative stress; Redox metals

Indexed keywords

CERULOPLASMIN; CLIOQUINOL; COPPER; DEFEROXAMINE; HYDROXYL RADICAL; IRON; NUCLEIC ACID; PENTETIC ACID; RIBOSOME RNA; RNA; TAU PROTEIN;

ALZHEIMER DISEASE; BINDING SITE; CENTRAL NERVOUS SYSTEM; CHELATION; CYTOSOL; DEPHOSPHORYLATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; METAL BINDING; MITOCHONDRION; NEUROFILAMENT; OXIDATION REDUCTION REACTION; PATHOGENESIS; PATHOLOGY; REVIEW; RIBOSOME;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; COPPER; CYTOSOL; HUMANS; IRON; MICROTUBULES; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 3042838351     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2004.01.002     Document Type: Review

References (51)

1. Aronov S., Aranda G., Behar L., Ginzburg I. Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal. J. Neurosci. 21:2001;6577-6587
2. Beckman J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler. 375:1994;81-88
3. Bush A.I. Copper, zinc, and the metallobiology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 17:2003;147-150
4. Cash A.D., Aliev G., Siedlak S.L., Nunomura A., Fujioka H., Zhu X., Raina A.K., Vinters H.V., Tabaton M., Johnson A.B., Paula-Barbosa M., Avila J., Jones P.K., Castellani R.J., Smith M.A., Perry G. Microtubule reduction in Alzheimer's disease and ageing is independent of tau filament formation. Am. J. Pathol. 162:2003;1623-1627
5. Castellani R.J., Smith M.A., Nunomura A., Harris P.L.R., Perry G. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin? Free Radic. Biol. Med. 26:1999;1508-1512
6. Castellani, R.J., Atwood, C.S., Perry, G., Petersen, R.B., Atwood, C., Smith, M.A., 2002. Prion and Alzheimer diseases: The road to pathogenesis is paved with copper. In: Brown, D.R. (Ed.). Prion Disease and Copper Metabolism: BSE, Scrapie and CJD Research, vol. 195-250, Chichester, Horwood Publishing. pp. 96-101.
7. Cherney R.A., Legg J.T., McLean C., Fairlie D.P., Huang X., Atwood C.S., Beyreuther K., Tanzi R.E., Masters C.L., Bush A.I. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J. Biol. Chem. 274:1999;23223-23228
8. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farraq Y.W., Perry G., Bush A.I. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275:2000;19439-19442
9. Curtain C.C., Ali F., Voltakis I., Cherney R.A., Norton R.S., Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., Barnham K.J. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276:2001;20466-20473
10. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28
11. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L.R., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21:2001;3017-3023
12. Joseph J., Shukitt-Hale B., Denisova N.A., Martin A., Perry G., Smith M.A. Copernicus revisted: amyloid beta in Alzheimer's disease. Neurobiol. Ageing. 22:2001;131-146
13. Keyse S.M., Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. U.S.A. 86:1989;99-103
14. Ledesma M.D., Bonay P., Colaco C., Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:1994;21614-21619
15. Loeffler D.A., LeWitt P.A., Juneau P.L., Sima A.A.F., Nguyen H.-U., deMaggio A.J., Brickman C.M., Brewer G.J., Dick R.D., Troyer M.D., Kanaley L. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 738:1996;265-274
16. Mattson M.P., Carney J.W., Butterfield D.A. A tombstone in Alzheimer's? Nature. 373:1995;481
17. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751
18. Mecocci P., Beal M.F., Cecchetti R., Polidori M.C., Cherubini A., Chionne F., Avellini L., Romano G., Senin U. Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol. Chem. Neuropathol. 31:1997;53-64
19. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14:1996;55-61
20. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19:1999;1959-1964
21. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59:2000;1011-1017
22. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767
23. Perry G., Castellani R.J., Hirai K., Smith M.A. Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimers Dis. 1:1998;45-55
24. Perry G., Nunomura A., Raina A.K., Smith M.A. Amyloid-β junkies. Lancet. 355:2000;757
25. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., Smith M.A. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs. 16:2002a;339-352
26. Perry G., Cash A.D., Srinivas R., Smith M.A. Metal and oxidative homeostasis in Alzheimer's disease. Drug Devel. Res. 56:2002b;293-299
27. Perry G., Taddeo M.A., Petersen R.B., Castellani R.J., Harris P.L.R., Siedlak S.L., Cash A.D., Liu Q., Nunomura A., Atwood C.S., Smith M.A. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals. 16:2003;77-81
28. Praprotnik D., Smith M.A., Richey P.L.R., Vinters H.V., Perry G. Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease. Acta Neuropathol. 91:1996;226-235
29. Premkumar D.R.D., Smith M.A., Richey P.L., Petersen R.B., Castellani R., Kutty R.K., Wiggert B., Perry G., Kalaria R.N. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 65:1995;1399-1402
30. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q.X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R.E., Masters C.L. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60:2003;1685-1691
31. Rottkamp C.A., Raina A.K., Zhu X., Gaier E., Bush A.I., Atwood C.S., Chevion M., Perry G., Smith M.A. Redox-active iron mediates amyloid-β toxicity. Free Radic. Biol. Med. 30:2001;447-450
32. Rottkamp C.A., Atwood C.S., Joseph J.A., Nunomura A., Perry G., Smith M.A. The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease. Peptides. 23:2002;1333-1341
33. Sampson J.B., Ye Y., Rosen H., Beckman J.S. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch. Biochem. Biophys. 356:1998;207-213
34. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097
35. Sayre, L.M., Perry, G., Smith, M.A., 1999. In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders. In: Wetzel, R. (Ed.). Methods of Enzymology, vol. 309. Academic Press, San Diego, pp. 133-152.
36. Sayre L.M., Perry G., Harris P.L.R., Liu Y., Schubert K.A., Smith M.A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74:2000;270-279
37. Schipper H.M., Cisse S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768
38. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91:1994a;5710-5714
39. Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994b;42-47
40. Smith M.A., Sayre L.M., Vitek M.P., Monnier V.M., Perry G. Early ageing and Alzheimer's. Nature. 374:1995;316
41. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121
42. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657
43. Smith M.A., Joseph J.A., Perry G. Arson: tracking the culprit in Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;35-38
44. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossini P.M. Elevation of serum copper levels in Alzheimer's disease. Neurology. 59:2002;1153-1161
45. Stieber A., Mourelatos Z., Gonatas N.K. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Pathol. 148:1996;415-426
46. Suzuki K., Terry R.D. Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia. Acta Neuropathol. 8:1967;276-284
47. Terry R.D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J. Neuropathol. Exp. Neurol. 55:1996;1023-1025
48. Terry R.D. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:2000;1118-1119
49. Terry R.D., Katzman R. Life span and synapses: will there be a primary senile dementia? Neurobiol. Ageing. 22:2001;347-348
50. Wataya T., Nunomura A., Smith M.A., Siedlak S.L., Harris P.L.R., Shimohama S., Szweda L.I., Kaminski M.A., Price D.L., Cleveland D.W., Sayre L.M., Perry G. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277:2002;4644-4648
51. Wong-Riley M., Antuono P., Ho K.C., Egan R., Hevner R., Liebl W., Huang Z., Rachel R., Jones J. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res. 37:1997;3593-3608